• Accueil >
  • Publications >
  • Prognostic value of the Residual Cancer Burden index according to breast cancer subtype: Validation on a cohort of BC patients treated by neoadjuvant chemotherapy

Prognostic value of the Residual Cancer Burden index according to breast cancer subtype: Validation on a cohort of BC patients treated by neoadjuvant chemotherapy

24 juin 2020PLOS ONE

DOI : 10.1371/journal.pone.0234191

Auteurs

Anne-Sophie Hamy, Lauren Darrigues, Enora Laas, Diane De Croze, Lucian Topciu, Giang-Thanh Lam, Clemence Evrevin, Sonia Rozette, Lucie Laot, Florence Lerebours, Jean-Yves Pierga, Marie Osdoit, Matthieu Faron, Jean-Guillaume Feron, Marick Laé, Fabien Reyal